J. Bigger

A. Moss, R. Case, J. Bigger, 2002, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

The Implantable Defibrillator: An Electronic Bridge to Cardiac Transplantation

V. Jeevanandam, J. Auteri, R. Michler, 1992, Circulation.

Predicting appropriate shocks in patients with heart failure: Patient level meta‐analysis from SCD‐HeFT and MADIT II

P. Kudenchuk, D. Mark, L. Inoue, 2016, Journal of cardiovascular electrophysiology.

Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?

P. Kudenchuk, D. Mark, L. Inoue, 2014, International journal of cardiology.

Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.

Paul L. Hess, Lurdes Y. T. Inoue, P. Kudenchuk, 2013, Heart rhythm.

Risk stratification and survival after myocardial infarction.

J. Fleiss, J. Miller, L. Kuller, 1983, The New England journal of medicine.

Association between ease of suppression of ventricular arrhythmia and survival.

Y. Pawitan, H. Kennedy, S. Goldstein, 1995, Circulation.

Therapy in the Cardiac Arrhythmia Suppression Trial

H. Kennedy, R. Bergstrand, S. Goldstein, 1994 .

Barriers, Enablers, and Incentives for Research Participation: A Report from the Ambulatory Care Research Network (ACRN)

Suzanne Bakken, J. Thomas Bigger, Rafael A. Lantigua, 2009, The Journal of the American Board of Family Medicine.

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.

Robert Lemery, M Huther, D Brill, 1992, The New England journal of medicine.

An analysis of the cost effectiveness of the implantable defibrillator.

J. Ruskin, B. Luce, J. Bigger, 1990, Circulation.

Beta-blocker therapy in the cardiac arrhythmia suppression trial

H. Kennedy, R. Bergstrand, S. Goldstein, 1994 .

Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.

P. Chan, S. Vijan, K. Stein, 2006, Journal of the American College of Cardiology.

Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials

P. Kudenchuk, D. Mark, L. Inoue, 2015, Circulation. Cardiovascular quality and outcomes.

Seasonal variation of mortality in the Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry.

Michael R Gold, R. Peters, M. Gold, 2004, Heart rhythm.

Case Report: Electronic Screening Improves Efficiency in Clinical Trial Recruitment

Chunhua Weng, David Wajngurt, J. Thomas Bigger, 2009, J. Am. Medical Informatics Assoc..

An Integrated Model for Patient Care and Clinical Trials (IMPACT) to support clinical research visit scheduling workflow for future learning health systems

George Hripcsak, Suzanne Bakken, Chunhua Weng, 2013, J. Biomed. Informatics.

Using EHRs to integrate research with patient care: promises and challenges

George Hripcsak, Chunhua Weng, Linda Busacca, 2012, J. Am. Medical Informatics Assoc..

From expert-derived user needs to user-perceived ease of use and usefulness: A two-phase mixed-methods evaluation framework

Suzanne Bakken, Chunhua Weng, Mary Regina Boland, 2014, J. Biomed. Informatics.

Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.

R. Califf, D. Mark, S. Connolly, 2005, American heart journal.

Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.

Joshua R. Smith, R. Califf, E. Fain, 2007, American heart journal.

Comparing the effectiveness of a clinical registry and a clinical data warehouse for supporting clinical trial recruitment: a case study.

Chunhua Weng, Adam Wilcox, Linda Busacca, 2010, AMIA ... Annual Symposium proceedings. AMIA Symposium.

A Day in the Life of a Clinical Research Coordinator: Observations from Community Practice Settings

Stephen B. Johnson, Philip R. O. Payne, Rita Kukafka, 2007, MedInfo.

Implantable cardioverter‐defibrillators in heart failure patients with reduced ejection fraction and diabetes

P. Kudenchuk, D. Mark, L. Inoue, 2018, European journal of heart failure.

Modeling Clinical Trials Workflow in Community Practice Settings

Stephen B. Johnson, Philip R. O. Payne, Rita Kukafka, 2006, AMIA.

Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials.

W. Zareba, R. Steinman, G. Siontis, 2013, Heart rhythm.

The antiarrhythmic effect of nortriptyline in cardiac patients with ventricular premature depolarizations.

J. Bigger, L. Johnson, J. Bigger, 1986, Journal of the American College of Cardiology.